PWM
NVAX icon

Palumbo Wealth Management’s Novavax NVAX Stock Holding History

Palumbo Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$876K Buy
92,947
+836
+0.9% +$7.49K 0.18% 87
2026
Q1 		$750K Buy
+92,111
New +$835K 0.18% 88
2025
Q4 		– Sell
-31,045
Closed -$269K – 227
2025
Q3 		$269K Buy
+31,045
New +$242K 0.09% 144

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Palumbo Wealth Management's NVAX Position: Q2 2026 in Review

Palumbo Wealth Management increased its Novavax (NVAX) stake by 0.91% in Q2 2026, buying an estimated $7.49K and bringing the position to 92,947 shares worth $876K. The position accounts for 0.18% of the portfolio, ranked #87.

Palumbo Wealth Management first reported a position in NVAX in Q3 2025 and has held it in 3 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Palumbo Wealth Management held 92,947 shares of Novavax worth $876K as of Q2 2026.
  • Palumbo Wealth Management bought 836 Novavax shares in Q2 2026, an estimated $7.49K.
  • Novavax made up 0.18% of Palumbo Wealth Management's portfolio in Q2 2026, its #87 holding.
  • Palumbo Wealth Management first reported a position in Novavax in Q3 2025 and has held it in 3 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.